Caixin
Jul 14, 2022 06:30 PM
BUSINESS

In Depth: Why China Still Doesn’t Have an mRNA Shot

Researchers show the trial process for developing an mRNA vaccine for Covid 19 in Shanghai in February 2020. Photo: VCG
Researchers show the trial process for developing an mRNA vaccine for Covid 19 in Shanghai in February 2020. Photo: VCG

As the fast-evolving coronavirus tests scientists’ capacity to develop more-effective vaccines, drugmakers in China are scrambling to catch up with the most advanced technology for producing more powerful shots to better protect the world’s largest population.

Since the pandemic started, China has approved seven home-grown Covid-19 vaccines using four proven technologies to back the country’s vaccination campaign, the world’s largest. But shots based on the new mRNA technology that have been widely used elsewhere are still not available in China. MRNA vaccines, led by products developed by Pfizer-BioNTech and Moderna, have outperformed most other shots in efficacy rates against Covid-19.

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
China Stories: The Rural Hardship Behind the Mine Murders That Shocked China
00:00
00:00/00:00